Schedule of reclassifications |
|
|
|
Three Months Ended December 31, 2019 |
|
|
|
As reported
|
|
Adjustment
|
|
|
As revised |
|
Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
1,638,840 |
|
|
(23,601
|
) |
|
1,615,239 |
|
Gross profit |
|
|
1,667,363 |
|
|
23,601 |
|
|
1,690,964 |
|
Product development |
|
|
1,261,509 |
|
|
(638,008
|
) |
|
623,501 |
|
Selling, general and administrative |
|
|
4,796,404 |
|
|
86,768 |
|
|
4,883,172 |
|
Net loss |
|
|
(4,338,536
|
) |
|
574,841 |
|
|
(3,763,695
|
) |
Net loss per share |
|
|
(0.40
|
) |
|
— |
|
|
(0.34
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2019
|
|
|
|
As reported |
|
Adjustment |
|
As revised |
|
Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
|
3,036,201 |
|
|
(41,261
|
) |
|
2,994,940 |
|
Gross profit |
|
|
3,462,892 |
|
|
41,261 |
|
|
3,504,153 |
|
Product development |
|
|
2,392,389 |
|
|
(1,157,986
|
) |
|
1,234,403 |
|
Selling, general and administrative |
|
|
8,380,219 |
|
|
104,667 |
|
|
8,484,886 |
|
Net loss |
|
|
(7,184,607
|
) |
|
1,094,580 |
|
|
(6,090,027
|
) |
Net loss per share |
|
|
(0.66
|
) |
|
— |
|
|
(0.56
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2020 |
|
|
|
As reported
|
|
Adjustment
|
|
|
As revised |
|
Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
1,420,909 |
|
|
(24,690 |
) |
|
1,396,219 |
|
Gross profit |
|
|
1,649,637 |
|
|
24,690 |
|
|
1,674,327 |
|
Product development |
|
|
1,632,353 |
|
|
(757,566 |
) |
|
874,787 |
|
Selling, general and administrative |
|
|
5,500,837 |
|
|
177,405 |
|
|
5,678,242 |
|
Net loss |
|
|
(5,348,980 |
) |
|
604,851 |
|
|
(4,744,129 |
) |
Net loss per share |
|
|
(0.43 |
) |
|
— |
|
|
(0.38 |
) |
|
|
|
|
|
|
|
|
|
|
|
|